Celesq® Attorneys Ed Center
Print Catalog:

Programs in Health Care Law

** URGENT UPDATE **

Our checkout cart is not currently working properly. In an effort to continue addressing your CLE needs, we would like to offer you a manual solution. Please go through our programs list. If you see a program that you would like to take to help satisfy your CLE needs, and it is past the program date (future dates are not yet available, of course), please send us the name of the program and the program number associated with it.

We will send you: 1) the audio file 2) the pdf of the presentation materials and 3) a manual affirmation form that you can fill out affirming that you listened to the entire program.

Once we receive the affirmations from you, we will issue manual certificates that you will be able to use to certify your CLE requirements.

Thank you so much and we apologize for the extreme inconvenience.

Please email customer.care@celesq.com with the above mentioned requests and we will get back to you as soon as possible!

Filter by State
Filter by Category
 
 

Navigating Venue and Multi-District Litigation in Hatch-Waxman Cases (04/22/2021)

Program Number: 3177 Presenter: Stanley E. Fisher, Esq., Michael Xun Liu, Esq.

In Valeant Pharmaceuticals v. Mylan Pharmaceuticals, the Federal Circuit clarified venue for Hatch-Waxman cases by holding that infringement only occurs where the ANDA filer took actions related to its ANDA submission, thereby resolving a split among district courts post-TC Heartland. This webinar will address the impact of Valeant on Hatch-Waxman litigation, including how it affects where cases can be filed and litigated. The webinar will also explain how litigants can use multi-district litigation to consolidate pre-trial proceedings in Hatch-Waxman cases, and discuss common issues that arise in multi-district patent litigation.

$95.00Audio Tape Add to Cart

It’s Not Personal, It’s Business: How Your Well-Being Could Impact Your Practice (04/21/2021)

Program Number: 3172 Presenter: Cindy Cieslak, Esq.

This presentation will address the real emotional and relational risks of being in the field of law. Attorneys will learn the importance of positive self-care as it may influence an attorney’s practice, and more specifically, an attorney’s ethical obligations under Rule 1.1 of the ABA Model Rules of Professional Conduct regarding competent representation, and Rule 1.15 regarding safekeeping of property, including client funds, and Rule 8.4 regarding misconduct.

$95.00Audio Tape Add to Cart

A New Workplace Safety Sherriff In Town: What Employers Should Expect from OSHA Under a Biden Administration (03/18/2021)

Program Number: 3160 Presenter: Dr. Sharon Meit Abrahams, Eric J. Conn, Esq.

President Biden has been sworn in and the transition from the Trump Administration is complete. It’s time to look ahead and assess what to expect from OSHA during the new year and the start of a new Democratic Administration. This program will review COVID-19, enforcement, rulemaking, and organizational developments at OSHA under a Biden Administration that employers need to know.

$95.00Audio Tape Add to Cart

A Shot in the Arm: The Employment and OSHA Law Implications of COVID-19 Vaccination Programs (03/15/2021)

Program Number: 3159 Presenter: Dr. Sharon Meit Abrahams, Eric J. Conn, Esq., Fern Fleisher-Daves, Esq.

In December 2020, two COVID-19 vaccines received emergency use authorization from the U.S. government and several more vaccines may be approved in the coming weeks. In the initial phases, front-line healthcare workers, nursing home residents, persons over 75 years of age, and others with underlying health conditions have been given first priority, but many employers are now devising programs to have their "essential workers" or all of their workers vaccinated as soon as possible. This discussion will address the OSHA and Labor & Employment law questions swirling around employer-driven vaccination policies and programs, including the legality of employer vaccine mandates, the grounds on which employees may decline the vaccine, and what effects the vaccine has on OSHA-required COVID-19 protocols in the workplace.

$95.00Audio Tape Add to Cart

Best Practices for Handling COVID Vaccine Issues in the Workplace (04/12/2021)

Program Number: 3158 Presenter: Dr. Sharon Meit Abrahams, Valerie C. Samuels, Esq.

Many employers are considering whether to require their employees to take the COVID vaccine. Employers want to return to a pre-COVID work environment as soon as possible. Many issues will arise concerning the vaccine, including disability accommodations for employees who cannot have the vaccine due to medical concerns and those who object for religious reasons. Other employee may refuse the vaccine due to safety concerns. Please join us for a lively and engaging presentation on how best to handle COVID vaccine issues in the workplace.

$95.00Audio Tape Add to Cart

Employers: There’s a Vaccine. Now What? (03/03/2021)

Program Number: 3157 Presenter: Helene R. Hechtkopf, Esq., Amory W. McAndrew, Esq.

This CLE will address questions that just about every employer is asking right now. Can they, – and should they –require employees to get the vaccine, to protect themselves and others in their workplaces; what can they do if an employee refuses to return to work if his or her co-workers are not vaccinated; and conversely, what to do if an employee refuses to get vaccinated on religious or other grounds. Finally, this CLE will analyze the recent EEOC guidance on vaccines in the employment context and run through relevant hypotheticals.

$95.00Audio Tape Add to Cart

Employer Strategies for When Off-duty Conduct Impacts the Workplace (03/09/2021)

Program Number: 3155 Presenter: Asima T. Ahmad, Esq., William J. Anthony, Esq., Brooke T. Iley, Esq.

Now more than ever, employees are engaging in off-duty conduct that impacts the workplace. From attendance at political rallies and social movements, posting on social media, and other outside conduct, employees’ activities are often on display for all to see. Whether the conduct paints the employer in a bad light, makes co-workers or customers uncomfortable, causes COVID-19 exposures or simply causes the employer to question whether to continue the individual’s employment, employers must keep in mind the myriad of laws, policies, business considerations and media attention that come into play when addressing outside activities. This program will give employers a roadmap for analyzing the legal, business and media risks associated with off-duty conduct by employees.

$95.00Audio Tape Add to Cart

Unpacking the Consolidated Appropriations Act – Health and Welfare Plans (03/17/2021)

Program Number: 3152 Presenter: Amy Gordon, Esq., Susan Nash, Esq.

This webinar will provide an overview of key legal requirements of the Consolidated Appropriations Act, 2021 applicable to health and welfare plans. Specifically, the program will discuss new legal requirements for group health plans and health insurance issuers with respect to: • New Surprise Billing Requirements • Transparency Rules • New Broker/Consultant Disclosure • Requirements • Permissible Cafeteria Plan Design Changes • Mental Health Parity Requirements Learning Objective: This webinar will provide practitioners with an overview of the key legal requirements of the Consolidated Appropriations Act, 2021 applicable to health and welfare benefit plans and an understanding of required and optional changes to benefit plan documents, participant disclosures and vendor contracts.

$95.00Audio Tape Add to Cart

FDA in the Year of COVID – How FDA Tackled the Pandemic and What to Expect from FDA in 2021 (02/11/2021)

Program Number: 3144 Presenter: Alexander Alfano, Esq., Michelle Divelbiss, Esq., Chad Landmon, Esq.

Over the past year, industries all over the world have experienced disruptions and have been forced to adapt to the COVID-19 pandemic. Notably, the Food and Drug Administration (“FDA”) has been thrust to the forefront of the battle against COVID-19, and emergency use authorizations (“EUAs”) and Operation Warp Speed are now hot topics. EUAs have allowed FDA to pivot and make speedy decisions that help save lives, but EUAs aren’t without their pitfalls. Additionally, Operation Warp Speed has been an impressive scientific endeavor, helping to bring vaccines to market in record time. As FDA has adapted quickly to the most up to date knowledge about this novel virus and changing scientific data, including real world evidence, what is in store for 2021? A new administration begins on January 20, 2020, and this new administration will bring different goals and plans for fighting COVID-19. Looking to 2021, we will see whether FDA’s operations

$95.00Audio Tape Add to Cart

Defamation in the Time of COVID-19 (02/02/2021)

Program Number: 3130 Presenter: Karen D. Fultz-Robinson, Esq., Johanna Sheehe, Esq.

As COVID-19 continues to threaten public health, worldwide, and serves as a major concern for individuals, questions surrounding the health of those interacting with the public, on a daily basis, are at the forefront of our discourse. This begs the question: Is a statement falsely advising that a person has contracted COVID-19 defamatory? This program will examine the elements required to maintain a claim for defamation in the context of COVID-19. The discussion will examine the challenges of proving whether a person has been defamed, examine the history of the loathsome disease category of defamation per se and its applicability to COVID-19 and damages associated with a statement regarding a person contracting COVID-19. Participants will gain an understanding of the legal elements required to prove a claim for defamation as well as the hurdles to prevail on such a claim as it relates to the pandemic.

$95.00Audio Tape Add to Cart

Categories